SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-005831
Filing Date
2023-04-18
Accepted
2023-04-18 11:39:29
Documents
14
Period of Report
2023-04-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K maia-8k_20230418.htm   iXBRL 8-K 43865
2 EX-99.1 maia-ex991_6.htm EX-99.1 19812
3 GRAPHIC g4tayn1podvq000001.jpg GRAPHIC 22319
  Complete submission text file 0001564590-23-005831.txt   232427

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA maia-20230418.xsd EX-101.SCH 5585
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230418_lab.xml EX-101.LAB 20221
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230418_pre.xml EX-101.PRE 11988
8 EXTRACTED XBRL INSTANCE DOCUMENT maia-8k_20230418_htm.xml XML 3699
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 23825954
SIC: 2834 Pharmaceutical Preparations